Cite
MLA Citation
Carolin Blumendeller et al.. “Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.” Journal for immunotherapy of cancer, vol. 9, no. 1, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100127565653.0x000033